Endogenous insulin secretion in critically ill patients
| dc.contributor.author | Pretty, C.G. | |
| dc.contributor.author | Lin, J. | |
| dc.contributor.author | Le Compte, A.J. | |
| dc.contributor.author | Shaw, Geoff | |
| dc.contributor.author | Chase, Geoff | |
| dc.date.accessioned | 2012-09-10T02:43:44Z | |
| dc.date.available | 2012-09-10T02:43:44Z | |
| dc.date.issued | 2012 | en |
| dc.description | 1-page | en |
| dc.description.abstract | Glucose-insulin system models can be used for improved glycemic control of critically ill patients. A key component of glucose-insulin models is pancreatic insulin secretion. There is limited data in the literature quantifying insulin secretion in critically ill patients at physiologic levels. This study presents a model pancreatic insulin secretion in critically ill patients based on data from a critically ill population. | en |
| dc.identifier.citation | Pretty, C.G., Lin, J., Le Compte, A.J., Shaw, G.M., Chase, J.G. (2012) Endogenous insulin secretion in critically ill patients. Brussels, Belgium: 32nd Symposium on Intensive Care and Emergency Medicine (ISICEM), 20-23 Mar 2012. Critical Care, 16, Supplement 1, P168. | en |
| dc.identifier.uri | http://hdl.handle.net/10092/6996 | |
| dc.language.iso | en | |
| dc.publisher | University of Canterbury. Mechanical Engineering | en |
| dc.rights.uri | https://hdl.handle.net/10092/17651 | en |
| dc.subject.anzsrc | Fields of Research::32 - Biomedical and clinical sciences::3202 - Clinical sciences::320212 - Intensive care | en |
| dc.subject.anzsrc | Fields of Research::32 - Biomedical and clinical sciences::3202 - Clinical sciences::320208 - Endocrinology | en |
| dc.title | Endogenous insulin secretion in critically ill patients | en |
| dc.type | Conference Contributions - Other |